1. MARKETS
  2. SECTOR : FMCG
  3. INDUSTRY : PACKAGED FOODS
  4. ZYDUS WELLNESS LTD.
Zydus Wellness Ltd.
NSE: ZYDUSWELL | BSE: 531335

Zydus Wellness Live Share Price Today, Share Analysis and Chart

Expensive Performer
BasketIn 2 Starfolio Baskets
aboutZydus Wellness Ltd. is a major consumer wellness company in India, operating in the FMCG sector with a focus on health-oriented products. The company holds leadership positions in several niche categories, including sugar substitutes and glucose powd... Read More
Ask AI about Zydus Wellness
462.75-16.75(-3.49%)

25.90% Gain from 52W Low

95,921
NSE+BSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Board Meeting
The next board meeting for Zydus Wellness is on 03 Nov 2026 for the purpose of Quarterly Results See details
Loading...
- / 100
- / 100
39.1 / 100
Expensive PerformerThese stocks are strong in quality but with mid-range technicals. Their valuations are expensiveView SimilarEmbed DVM
Analyst Price Target
-

6

S

13

W

4

O

3

T

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

High rank

12Positive11Negative

Pass in checklist52.2%

045
55
100

PE Valuation Check

Right Now
Overvalued
-45.2%
1 Year Forward
Undervalued
16.3%
INSIGHTZydus Wellness is overvalued at current PE, but undervalued on future earnings estimates

Zydus Wellness Stock Price Analysis

Day Price Range

-3.5% 1 Day return
462.8 (LTP)
459481
LowHigh

Week Price Range

-0.1% 1 Week return
462.8 (LTP)
455484.9
LowHigh

Month Price Range

-9.8% 1 Month return
462.8 (LTP)
454.4520
LowHigh

52 Week Price Range

-2.9% 1 Year return
462.8 (LTP)
367.6611.8
LowHigh
View full Price History/Seasonality

Zydus Wellness Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Hit

Zydus Wellness's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

CURRENT EPS
6.2
AVG. ESTIMATE
12.1
LOW ESTIMATE
10.7
HIGH ESTIMATE
14.4
CURRENT EPS
AVG. ESTIMATE
Hit

EPS is expected to grow by 94.4% in FY27

Consensus Recommendation

8 ANALYST Recommendations
STRONG BUY

The consensus recommendation from 8 analysts for Zydus Wellness is STRONG BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get
Upgrade Now

Zydus Wellness Technical Analysis

Zydus Wellness EMA & SMA

Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
5 Day471.1
10 Day478.4
12 Day481.0
20 Day489.6
26 Day494.8
50 Day507.7
100 Day512.0
200 Day496.9

Zydus Wellness Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202647.8%
Week44.8%
Month45.8%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Zydus Wellness Resistance and Support

467.57
Pivot
First Resistance476.2
Second Resistance489.6
Third Resistance498.2
First Support454.1
Second Support445.5
Third Support432.1
Day RSI38
Day MACD-13.8
Day MFI51.1
Day MACD Signal Line-11.6

Zydus Wellness Beta

1 Month0.8
1 Year0.6
3 Month0.4
3 Year0.5

Zydus Wellness Price Change Analysis

↓-9.8%
Over 1 Month
LowHigh
454.5520
↓-19.9%
Over 3 Months
LowHigh
454.5581
↓-9.0%
Over 6 Months
LowHigh
454.5611.9
↓-2.9%
Over 1 Year
LowHigh
367.6611.9
All Technicals →

Zydus Wellness Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Zydus Lifesciences LimitedPromoter183,237,54557.6 %
Parag Parikh Flexi Cap FundDii23,320,7747.3 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Zydus Wellness Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
IRAGE BROKING SERVICES LLPBulkSell13 Mar 2026425.391,664,411NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkSell13 Mar 2026428.823,136,345NSE
IRAGE BROKING SERVICES LLPBulkPurchase13 Mar 2026428.751,701,292NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDBulkPurchase13 Mar 2026428.533,136,345NSE
THREPSI CARE LLPBlockSell17 Jun 202519004,627,111NSE
PPFAS MUTUAL FUNDBlockPurchase17 Jun 202519004,627,111NSE
THREPSI CARE LLPBulkSell17 Jun 202519004,627,111NSE
PPFAS MUTUAL FUNDBulkPurchase17 Jun 202519004,627,111NSE
THREPSI CARE LLPBlockSell06 Aug 20242201.401,700,000NSE
QUANT MUTUAL FUNDBlockPurchase06 Aug 20242201.401,700,000NSE
All deals
All insider trades

Zydus Wellness Corporate Actions

Zydus Wellness Dividend history and yield

Zydus Wellness dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Zydus Wellness dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
117 Jul 2026
1.2FINAL17 Jul 2026Equity Share
211 Jul 2025
6FINAL11 Jul 2025Equity Share
319 Jul 2024
5FINAL19 Jul 2024Equity Share
421 Jul 2023
5FINAL21 Jul 2023Equity Share
514 Jul 2022
5FINAL15 Jul 2022Equity Share

Zydus Wellness Board Meetings

Zydus Wellness past and upcoming board meetings.

#Ex-Date
PurposeNotes
103 Nov 2026
Quarterly Results-
204 Aug 2026
Quarterly Results-
318 May 2026
Audited Results & Final Dividend-
403 Feb 2026
Quarterly Results-
505 Nov 2025
Quarterly Results-

Zydus Wellness Stock Split

Zydus Wellness stock split details, including announcement, record, and ex-split dates, along with the split ratios

#Ex-Date
Old FVNew FVRecord Date
118 Sep 2025
10218 Sep 2025
All Corporate Actions

Zydus Wellness Research Reports

Zydus Wellness research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
103 Aug 2026Motilal Oswal
Target
665550.2Buy20.87%-15.89%pdf
218 May 2026BP Wealth-509.1Results Update--9.1%pdf
317 May 2026BOB Capital Markets Ltd.-495.65Not Rated--6.64%pdf
403 Feb 2026BP Wealth-401.25Results Update-15.33%pdf
530 Dec 2025Motilal Oswal575424Buy35.61%9.14%pdf
All Reports of Zydus

Zydus Wellness Corporate Filings

Zydus Wellness BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
23 Oct 2026
Zydus Wellness Ltd-$ - 531335 - Clarification On Recent News Item Dated October 22, 2026
Clarification on recent news item dated October 22, 2026
PDF
22 Oct 2026
Zydus Wellness Ltd-$ - 531335 - Clarification sought from Zydus Wellness Ltd
The Exchange has sought Clarification from Zydus Wellness Ltd with reference to the media report appearing on https://www.firstpost.com dated October 22, 2026 titled "FSSAI issues notices to Nestle India, Zydus Wellness over alleged misleading product claims" (Link: https://www.firstpost.com/business/fssai-issues-notices-to-nestle-india-zydus-wellness-over-alleged-misleading-product-claims-14054416.html).The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015.
PDF
19 Oct 2026
Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Analyst / Institutional Investors' call on November 3, 2026
PDF
16 Oct 2026
Zydus Wellness Ltd-$ - 531335 - ESG Rating Assigned By NSE Sustainability Ratings And Analytics Limited
ESG rating
PDF
15 Oct 2026
Zydus Wellness Ltd-$ - 531335 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended On September 30, 2026
Zydus Wellness Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended on September 30, 2026
PDF
VIEW ALL

Zydus Wellness DocumentsAsk MarketMind AI

Zydus Wellness Earnings Call

Zydus Wellness earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
10 Aug 2026Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeLink
04 Aug 2026Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeLink
04 Aug 2026Zydus Wellness Results Earnings Call for Q1FY27AudioVideo
18 May 2026Zydus Wellness Results Earnings Call for Q4FY26 & Full YearAudioVideo
03 Feb 2026Zydus Wellness Results Earnings Call for Q3FY26AudioVideo
view all

Zydus Wellness Annual Reports

Zydus Wellness financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026Link
2025Annual Report Mar-2025Link
2024Annual Report Mar-2024Link
2023Annual Report Mar-2023Link
2022Annual Report Mar-2022Link

Zydus Wellness Credit Ratings

Zydus Wellness credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
21 Oct 2026crisil ratingsZydus Lifesciences LimitedZydus Lifesciences Limited:Update on Zydus Lifesciences LimitedLink
08 Sep 2026crisil ratingsZydus Lifesciences LimitedZydus Lifesciences Limited:Ratings reaffirmed at 'Crisil AAA / Stable / Crisil A1+ 'Link
18 Aug 2026care ratingsZydus Wellness Products LimitedLink
26 Mar 2026crisil ratingsZydus Healthcare LimitedZydus Healthcare Limited:Ratings reaffirmed at 'Crisil AAA / Stable / Crisil A1+ 'Link
08 Sep 2025crisil ratingsZydus Lifesciences LimitedZydus Lifesciences Limited:Ratings reaffirmed at 'Crisil AAA/Stable/Crisil A1+'Link

Zydus Wellness Investor Presentations

Zydus Wellness investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
04 Aug 2026Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
18 May 2026Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
18 Mar 2026Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
16 Mar 2026Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
03 Feb 2026Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Investor PresentationLink

Zydus Wellness - Company Profile

Zydus Wellness Management Structure

Zydus Wellness management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Umesh V. ParikhChief Financial Officer(Finance,Information Technology)-Mar 26
Nandish P. JoshiCompany Secretary,Compliance Officer-Mar 26
Mr. Lalit AhujaHead(Sales)-Mar 26
Mr. Shantanu DasHuman Resources-Mar 26
Mr. Himanshu PandeyManufacturing Manager-Mar 26
Mr. Manish LalHead(Global,Supply Management)-Mar 26
Mr. Arijit SenguptaMarketing-Mar 26
Mr. Manish JoshiHead(Business Development,Projects)-Mar 26
Mr. R. Phani KumarHead(Quality,Regulatory.)-Mar 26
Mr. Bhupesh DesaleHead(NEO & PMG,Foods.,Vertical)-Mar 26
Mr. Santosh ManeLegal Officer(Legal.)-Mar 26
Tarun AroraExecutive Director,Whole Time Director,Chief Executive Officer-Mar 26

Zydus Wellness Board of Directors

Zydus Wellness Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
N Sri Vishnu RajuIndependent Non Exe. Director19.5Mar 26
Kulin S LalbhaiIndependent Non Exe. Director19.5Mar 26
Dharmishta N RavalIndependent Non Exe. Director18.5Mar 26
Akhil A. MonappaIndependent Non Exe. Director13.5Mar 26
Ganesh N NayakNon-Exec & Non-Independent Dir11Mar 26
Sharvil P PatelChairman(Non Exe)&Dir(Non-Ind)7Mar 26
A S DiwanjiIndependent Non Exe. Director-Mar 26
Tarun AroraExecutive Director / Whole Time Director / CEO-Mar 26
Nandish P. JoshiCompany Sec. & Compli. Officer-Mar 26
Website: www.zyduswellness.com

About the company - Business Profile

Zydus Wellness Ltd. is a major consumer wellness company in India, operating in the FMCG sector with a focus on health-oriented products. The company holds leadership positions in several niche categories, including sugar substitutes and glucose powders. Headquartered in Ahmedabad, Zydus Wellness manages a portfolio of established brands such as Glucon-D, Sugar Free, Complan, Nycil, Everyuth, and Nutralite. It operates as a subsidiary of the Zydus group, leveraging research and development to offer differentiated products across food, nutrition, and personal care segments.

Key Points

  • Key Facts:
    • Founded: Incorporated in 1994.
    • Headquarters: Ahmedabad, Gujarat.
    • Stock Listing: Listed on NSE (ZYDUSWELL) and BSE.
    • Parent Company: Part of the Zydus Lifesciences Group.
    • Primary Products: Glucon-D, Sugar Free, Complan, Nycil, Everyuth, and Nutralite.
  • Operations and Resources:
    • Facilities: Operates multiple manufacturing facilities across India.
    • Distribution: Robust network of over 1,700+ distributors and 2,500 feet-on-street representatives.
    • Logistics: Supported by 24 integrated warehouses capable of managing both cold chain and ambient product ranges.
  • Market Position and Significance:
    • Market Leadership: Holds a 59.5% market share in the Glucose Powder category (Glucon-D) and a 95.9% market share in the Sugar Substitute category (Sugar Free).
    • Reach: Household penetration is reported to be nearly four times higher than the overall market average, with strong growth observed in rural markets.
  • Business Model and Strengths:
    • Model: Focuses on developing and marketing health and wellness products with functional benefits.
    • Core Competency: Strong brand equity in niche health-focused FMCG categories and an extensive pan-India distribution reach.
  • Financial Performance (FY 2024-25):
    • Net Sales: Rs. 26,912 million, reflecting a growth of 16.2% year-on-year.
    • Total Income from Operations: Rs. 27,089 million.
    • EBITDA: Rs. 3,797 million with an EBITDA margin of 14.0%.
    • Net Profit: Rs. 3,469 million, a 30.0% increase compared to the previous year.
    • Segment Performance: The Personal Care segment saw a robust growth of 33.4% during FY 2024-25.
  • Product and Technology Advancements:
    • Innovation: Expansion of the "Sugar Free" brand into healthier cookies and chocolates.
    • New Offerings: Launch of Ready-To-Drink (RTD) variants for Glucon-D to tap into the on-the-go hydration segment.
    • Portfolio Expansion: High-protein offerings under the "RiteBite Max Protein" brand and functional skincare under "Everyuth" and "Cuticolor."
  • Employee and Organizational Metrics:
    • Total Employees: Approximately 818 permanent and non-permanent employees, and 2,551 workers (as of March 31, 2024).
    • Workplace Culture: Certified as a "Great Place to Work" for four consecutive years.
  • Recent Strategic Initiatives:
    • Acquisitions: Recently acquired the Comfort Click portfolio, expanding its footprint in the international wellness market, specifically in the UK.
    • International Presence: Growing footprint in markets including the UK, UAE (Zydus Wellness International DMCC), and Bangladesh.
    • Sustainability: Focused on ESG (Environmental, Social, and Governance) highlights and natural ingredient-led product development.

References

  1. Annual Report May 2025
  2. Investor Presentation Feb 2026
  3. Investor Presentation Nov 2025
  4. Annual Report May 2024

Zydus Wellness FAQ

Zydus Wellness today is trading in the red, down by 3.49% at ₹462.75.
Zydus Wellness is currently trading down 3.49% on an intraday basis. In the past week the stock fell 0.13%. Stock has been down 19.88% in the past quarter and fell 2.91% in the past year. You can view this in the share price history/seasonality section.
Zydus Wellness is listed on NSE with the ticker ZYDUSWELL and on BSE as 531335. It's currently trading on NSE at a share price of ₹462.75 and on BSE with a share price of ₹461.4.
The market cap of Zydus Wellness is ₹14,722.89 Cr. as of Oct 30, 2026.
Zydus Wellness announced a FINAL dividend of 60% which equals ₹1.2 in Jul 17, 2026.The last three ex-dates for Zydus Wellness were Jul 11, 2025, Jul 19, 2024 and Jul 21, 2023. To view the full dividend history of Zydus Wellness click here.
Zydus Wellness has never issued bonus shares, but it has issued 1 stock split since its BSE/NSE listing. The latest announcement for Zydus Wellness stock split was on Sep 18, 2025 at a ratio of 10:2.
Zydus Wellness reported ₹1,440.8 Cr. in revenue, ₹118.9 Cr. in net profit, and ₹245.5 Cr. in EBITD as of Aug 04, 2026 for Q1 FY26-27.
According to the predictions of 8 analysts, the share price prediction for Zydus Wellness is ₹602.63 with an upside of 30%.
The PE ratio of Zydus Wellness is 78.23 as of Oct 30, 2026.
The PB ratio of Zydus Wellness is 2.48 as of Oct 30, 2026.
You can view the latest analyst reports on the Zydus Wellness reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.
Ask AI
×